The Commission on Narcotic Drugs (CND) will host a number of thematic discussions on the implementation of the outcome document of the United Nations General Assembly Special Session (UNGASS) on the world drug problem on 10-11 October and 27-28 October 2016 in Vienna, Austria. NGOs are encouraged to work through the VNGOC to coordinate contributions, in order to ensure an inclusive, comprehensive, balanced and meaningful civil society participation. At this moment in time, the discussion will focus on concrete actions currently taken by various stakeholders at various levels to implement the UNGASS outcome document, rather than on policy prescriptions.

2-4 NGO contributions per UNGASS outcome document chapter can be accommodated. With a view to having an interactive discussion, H.E. Ambassador Pedro Moitinho, CND Facilitator on post-UNGASS 2016, has agreed to call, if possible, for statements by NGOs during the thematic discussions.

A selection of civil society statements at the Intersessional Meeting

Timeline for CND intersessional meeting 27-28 October 2016:

- applicants fill out the application form by 20 October 2016 at 12:00 p.m. (CEST, Vienna local time)
- selection of applicants to be conducted on 20-21 October 2016
- selected speakers will be notified on 21 October 2016
- list of selected NGO speakers to be sent by the VNGOC to the CND Secretariat on 21 October 2016.
- statements and pre-recorded video messages to be shared by selected speakers by 26 October 2016 at 12:00 p.m. (CEST, Vienna local time)
- statements and pre-recorded video messages to be shared by the VNGOC with the CND Secretariat on 26 October 2016.
These meetings will be web cast on the UNODC web site (more info on this, once available). Also, there is the opportunity to submit the statements delivered and others directly related to the implementation of the UNGASS outcome document recommendations for posting on the UNODC web site. The VNGOC will coordinate the posting of the former, while others may be submitted to the CND Secretariat directly.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.